APA (7th ed.) Citation

S, I., A, K., Y, I., Y, I., Y, T., C, U., . . . K, N. (2024). Evaluation of pathogenicity of WT1 intron variants by in vitro splicing analysis. Clinical and experimental nephrology, 28(11), 1075. https://doi.org/10.1007/s10157-024-02510-w

Chicago Style (17th ed.) Citation

S, Inoue, et al. "Evaluation of Pathogenicity of WT1 Intron Variants by in Vitro Splicing Analysis." Clinical and Experimental Nephrology 28, no. 11 (2024): 1075. https://doi.org/10.1007/s10157-024-02510-w.

MLA (9th ed.) Citation

S, Inoue, et al. "Evaluation of Pathogenicity of WT1 Intron Variants by in Vitro Splicing Analysis." Clinical and Experimental Nephrology, vol. 28, no. 11, 2024, p. 1075, https://doi.org/10.1007/s10157-024-02510-w.